| Literature DB >> 25395096 |
Juan Jose Carmona, Tamar Sofer, John Hutchinson, Laura Cantone, Brent Coull, Arnab Maity, Pantel Vokonas, Xihong Lin, Joel Schwartz, Andrea A Baccarelli1.
Abstract
BACKGROUND: Exposure to air particulate matter is known to elevate blood biomarkers of inflammation and to increase cardiopulmonary morbidity and mortality. Major components of airborne particulate matter typically include black carbon from traffic and sulfates from coal-burning power plants. DNA methylation is thought to be sensitive to these environmental toxins and possibly mediate environmental effects on clinical outcomes via regulation of gene networks. The underlying mechanisms may include epigenetic modulation of major inflammatory pathways, yet the details remain unclear.Entities:
Mesh:
Substances:
Year: 2014 PMID: 25395096 PMCID: PMC4273424 DOI: 10.1186/1476-069X-13-94
Source DB: PubMed Journal: Environ Health ISSN: 1476-069X Impact factor: 5.984
The 84 MAPK pathway-linked genes considered in our analyses
| Gene | Gene | Gene | |||
|---|---|---|---|---|---|
| 01 |
| 38 |
| 73 |
|
| 02 |
| 39 |
| 74 |
|
| 03 |
| 40 |
| 75 |
|
| 04 |
| 41 |
| 76 |
|
| 05 |
| 42 |
| 77 |
|
| 06 |
| 43 |
| 78 |
|
| 07 |
| 44 |
| 79 |
|
| 08 |
| 45 |
| 80 |
|
| 09 |
| 46 |
| 81 |
|
| 10 |
| 47 |
| 82 |
|
| 11 |
| 48 |
| 83 |
|
| 12 |
| 49 |
| 84 |
|
| 13 |
| 45 |
| ||
| 14 |
| 50 |
| ||
| 15 |
| 51 |
| ||
| 16 |
| 52 |
| ||
| 17 |
| 53 |
| ||
| 18 |
| 54 |
| ||
| 19 |
| 50 |
| ||
| 20 |
| 55 |
| ||
| 21 |
| 56 |
| ||
| 22 |
| 57 |
| ||
| 23 |
| 58 |
| ||
| 24 |
| 59 |
| ||
| 25 |
| 60 |
| ||
| 26 |
| 61 |
| ||
| 27 |
| 62 |
| ||
| 28 |
| 63 |
| ||
| 29 |
| 64 |
| ||
| 30 |
| 65 |
| ||
| 31 |
| 66 |
| ||
| 32 |
| 67 |
| ||
| 33 |
| 68 |
| ||
| 34 |
| 69 |
| ||
| 35 |
| 70 |
| ||
| 36 |
| 71 |
| ||
| 37 |
| 72 |
|
To our knowledge, this is the first human study to systematically evaluate MAPK gene-promoter methylation using a wide collection of upstream and downstream pathway components with respect to ambient air pollution exposures.
Summary of relevant NAS characteristics used in this study: complete set and subset of participants who had sulfate measures available (n =90), out of a total of 141 participants
| NAS cohort description | All participants | With sulfate measures |
|---|---|---|
|
| n = 141 people | n = 90 people |
| Median 73; Range 56–88; SD ±6.8 | Median 73; Range 58–88; SD ±6.6 | |
|
| n = 141 | n = 90 |
| Systolic | Median 130; Range 87–188; SD ±16.13 | Median 129.5; Range 87–188; SD ±15.65 |
| Diastolic | Median 79; Range 54–98; SD ±9.1 | Median 78; Range 55–96; SD ±9.11 |
|
| n = 141 | n = 90 |
| BC, 30-days averaged | Mean 0.84; SD ±0.16 | Mean 0.83; SD ±0.15 |
| Sulfate, 30-days averaged | N/A | Mean 3.06; SD ±0.79 |
|
| n = 141 | n = 90 |
| Never | 53 | 32 |
| Ever | 7 | 5 |
| Former | 81 | 53 |
|
| n = 136 | n = 88 |
| Lymphocytes | Median 26; Range 6–39; SD ±6.66 | Median 26; Range 6–38; SD ±6.92 |
| Neutrophils | Median 62; Range 45–86; SD ±7.71 | Median 63; Range 45–86; SD ±7.78 |
| Monocytes | Median 9; Range 4–14; SD ±1.92 | Median 8; Range 4–14; SD ±1.96 |
| Basophils | Median 1; Range 0–2; SD ±0.51 | Median 1; Range 0–2; SD ±0.52 |
| Eosinophils | Median 3; Range 0–11; SD ±1.9 | Median 3; Range 0–10; SD ±1.83 |
Relevant units are supplied in the left-hand side for each characteristic, with median (or mean), range, standard deviation, and sample size indicated.
Results of the stepwise-CCA algorithm applied to the MAP kinase pathway genes, grouped by exposure-specific model
| Weighted coefficients by exposure model | |||
|---|---|---|---|
| ID | Black Carbon (BC) | Sulfates (S) | Multi (BCS) |
| BC | 1 | 0 | 0.49 |
| S | 0 | 1 | −1.08 |
|
| 0.39 | 0 | 0 |
|
| 0 | 0.5 | −0.36 |
|
| 0.29 | −0.51 | 0 |
|
| 0.65 | 0 | 0 |
|
| 0 | 0.13 | −0.22 |
|
| 0 | 0 | −0.3 |
|
| 0 | 0 | 0.42 |
|
| 0 | 0 | 0.22 |
|
| 0 | −0.4 | 0 |
|
| 0 | 0 | 0.37 |
|
| −0.25 | 0 | 0 |
|
| −0.37 | 0 | 0 |
|
| 0 | 0.41 | 0 |
|
| 0 | −0.19 | 0.31 |
|
| 0.42 | 0 | 0 |
|
| 0 | 0.57 | −0.61 |
|
| −1.36 | 0.62 | 0 |
|
| 0.32 | 0 | 0.33 |
|
| 0 | 0 | −0.57 |
|
| 0 | −0.28 | 0.09 |
|
| 0.27 | 0 | 0 |
|
| 0 | −0.33 | 0 |
|
| 0.33 | 0 | 0 |
|
| 0 | −0.49 | 0.43 |
|
| 0 | 0.28 | 0 |
|
| 0 | 0 | 0.23 |
|
| 0.27 | 0 | 0.48 |
| Canonical correlation | 0.73 | 0.73 | 0.78 |
| P-value* | 0.02 | 0.04 | 0.05 |
| P-value** | 0.04 | 0.10 | 0.01 |
We identified a cluster of 27 MAPK gene hits, and their corresponding weights (as coefficients after 3K permutation tests) are shown. At the bottom of the table, P-values for each model are labeled as either adjusted for all covariates, with two asterisks (**), or for all covariates except blood cell proportions, with one asterisk (*).
Figure 1Summary of all possible relationships between MAPK pathway gene hits as grouped by exposure model. All of the MAPK genes from Table 3 are grouped here by their exposure-specific model: black carbon (BC); sulfates (S); and multi-exposure for BC and sulfates (BCS). The various sections of this Venn diagram are color-coded to help identify gene subgroups within each region of the figure. The DNA methylation status of each gene is summarized as either increased (green) or decreased (red).
Figure 2Methylation coefficients of our (epi)gene hits within the broader MAPK signaling system. A nexus integrating all BioCarta MAP kinase genes to other previously studied MAPK networks is diagramed, wherein nodes representing the genes within the BioCarta MAP kinase pathway (84 total) are outlined and labeled in dark black. Arrows indicate known direction of action. Methylation coefficients (from Table 3) are represented here in a scale from blue (negative values), to white (zero), to orange (positive values). For simplicity, both unmeasured values and zero are represented in white. Exposure-specific MAPK coefficients are shown across all three of our models: (a) black carbon; (b) sulfates; and (c) the multi-pollutant paradigm.
Figure 3Biocomputational profiling of disease-linked MAPK (epi)gene hits. A heatmap (left) of methylation coefficients for the three pollution paradigms—black carbon (BC), sulfates (S), and BC with sulfate (BCS)—and a corresponding disease ontology table (right) are shown. Only genes with an annotation within the disease ontology [51] are shown: i.e., 11 out of 27 MAPK genes (~41%). Heatmap colors represent the methylation coefficients, with negative values in blue, zero in white, and positive values in red. Rows within both the heatmap and the concept-map represent individual genes as noted. Columns within the disease ontology concept-map represent individual diseases within the disease ontology. Disease category hierarchies were collapsed, so diseases may represent subcategories of other diseases represented (e.g., “Breast cancer” and “Ovarian cancer” are both sub-categories of “Cancer”). Dots within the disease ontology table denote an association of a gene with a given pathology. Alternative shading is used to help demarcate columns.
Complete list of the NF-κB signaling pathway and associated genes (22 total) considered in this study
| Gene | Gene | ||
|---|---|---|---|
| 01 |
| 12 |
|
| 02 |
| 13 |
|
| 03 |
| 14 |
|
| 04 |
| 15 |
|
| 05 |
| 16 |
|
| 06 |
| 17 |
|
| 07 |
| 18 |
|
| 08 |
| 19 |
|
| 09 |
| 20 |
|
| 10 |
| 21 |
|
| 11 |
| 22 |
|
Despite the fact that 8 out of these 22 genes denoted by a dagger (†) were shared by the MAPK pathway list in Table 1 (~36% overlap), our stepwise-CCA method failed to identify any statistically significant NF-κB gene clusters for any of the three exposure paradigms.
No significant associations were obtained between NF-κB genes and the exposure models tested
| Weighted coefficients by exposure model | |||
|---|---|---|---|
| ID | Black Carbon (BC) | Sulfates (S) | Multi (BCS) |
| BC | 1 | 0 | −0.49 |
| S | 0 | 1 | 1.08 |
|
| −0.96 | 0 | 0 |
|
| 0 | −0.54 | 0 |
|
| 0 | 0.82 | 1 |
|
| 1.15 | 0 | 0 |
| Canonical correlation | 0.23 | 0.28 | 0.24 |
| P-value* | 0.88 | 0.61 | 0.81 |
| P-value** | 0.98 | 0.54 | 0.84 |
P-values for each model are indicated as either adjusted for all covariates (**) or all covariates except blood cell proportions (*).